| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 84880-03-5 | 頭孢咪唑; (6R,7R)-7-[[(2R)-2-[(5-羧基-1H-咪唑-4-甲酰)氨基]-2-苯基乙酰]氨基]-8-氧代-3-[[4-(2-磺酸基乙? | Cefpimizole; (6R,7R)-7-[[(2R)-2-[(5-carboxy-1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino]-8-oxo-3-[[4-(2-sulfonatoethyl)pyridin-1-ium-1-yl]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |  | C28H26N6O10S2 | 詳情 | 供應商 |
| 85287-61-2 | 頭孢咪唑鈉; (6R,7R)-7-[[(2R)-2-[(2-羧基-3H-咪唑-4-甲酰)氨基]-2-苯基乙酰]氨基]-8-氧代-3-[[4-(2-磺酸基? | Cefpimizole sodium; Sodium (6R,7R)-7-[[(2R)-2-[(2-carboxy-3H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino]-8-oxo-3-[[4-(2-sulfonatoethyl)pyridin-1-ium-1-yl]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |  | C28H25N6NaO10S2 | 詳情 | 供應商 |
| 152628-03-0 | 2-正丙基-4-甲基-6-羧基苯并咪唑; 2-正丙基-4-甲基苯并咪唑-6-羧酸 | 4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid; 4-Methyl-2-propyl-6-benzimidazolecarboxylicacid |  | C12H14N2O2 | 詳情 | 供應商 |
| 133040-01-4 | 依普沙坦; 依普沙坦; (E)- Α-[[2-丁基-1-[(4-羧基苯基)甲基]-1H-咪唑-5-基]亞甲基]-2-噻吩丙酸 | 2-Thiophenepropanoicacid, a-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-,(aE)-; 2-Thiophenepropanoicacid, a-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-,(E)-; (E)-2-Butyl-1-(p-carboxybenzyl)-a-2-thenylimidazole-5-acrylic acid; Eprosartan; SKB108566; SKF 108566; Teveten |  | C23H24N2O4S | 詳情 | 供應商 |